Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Medication-induced”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableNot Yet RecruitingNCT07715994
What this trial is testing

A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

Who this might be right for
Extrapyramidal SymptomsDrug-induced ParkinsonismAkathisia, Drug-Induced+1 more
Shanghai Mental Health Center 180
Not applicableEnded earlyNCT02524886
What this trial is testing

Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia

Who this might be right for
Tardive DyskinesiaTardive Dystonia
GGZ Centraal 1
Post-approval studies (Phase 4)Study completedNCT03698331
What this trial is testing

The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 89
Testing effectiveness (Phase 2)Ended earlyNCT00917293
What this trial is testing

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Medicure 53
Large-scale testing (Phase 3)Study completedNCT02736955
What this trial is testing

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 161
Not applicableLooking for participantsNCT07173920
What this trial is testing

Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

Who this might be right for
Tardive DyskinesiaRepetitive Transcranial Magnetic Stimulation
Peking University Sixth Hospital 62
Testing effectiveness (Phase 2)Study completedNCT01921270
What this trial is testing

Dysport for the Treatment of OMD

Who this might be right for
Oral DystoniaTardive Dystonia
Emory University 18
Not applicableUnknownNCT03062033
What this trial is testing

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 70
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Testing effectiveness (Phase 2)Study completedNCT01733121
What this trial is testing

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 102
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Not applicableLooking for participantsNCT05317390
What this trial is testing

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Who this might be right for
DystoniaDrug Induced DystoniaParkinson Disease+8 more
Massachusetts Eye and Ear Infirmary 1,000
Testing effectiveness (Phase 2)Study completedNCT01176721
What this trial is testing

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
cerbomed GmbH 20
Testing effectiveness (Phase 2)Study completedNCT00401089
What this trial is testing

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderTardive Dyskinesia+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Not applicableUnknownNCT01804920
What this trial is testing

D-Serine Treatment For Tardive Dyskinesia

Who this might be right for
Schizophrenia and Schizoaffective DisorderTardive Dyskinesia
Herzog Hospital 16
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Not applicableUnknownNCT06011408
What this trial is testing

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Who this might be right for
Tardive Dyskinesia
iRxReminder 300
Testing effectiveness (Phase 2)WithdrawnNCT00621634
What this trial is testing

Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Université de Montréal
Post-approval studies (Phase 4)UnknownNCT00837707
What this trial is testing

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Drug-Induced
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25
Next Page